Juniper Pharmaceuticals Inc (JNP) - Financial and Strategic SWOT Analysis Review

Juniper Pharmaceuticals Inc (JNP) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH63040FSA
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Juniper Pharmaceuticals Inc (JNP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women's health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company utilizes proprietary drug delivery technologies to treat various medical conditions to commercial partners. Its proprietary technology includes intravaginal ring (IVR) and bioadhesive gel (BDS). Juniper provides a range of drug development services and consulting services to the pharmaceutical industry. The company operates in pharmaceutical industry and also provides in-house expertise for internal pharmaceutical programs. The company operates in the US, the UK, Switzerland and other countries. Juniper is headquartered in Boston, Massachusetts, the US.

Juniper Pharmaceuticals Inc Key Recent Developments

May 10,2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Mar 21,2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

Mar 08,2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Jan 31,2018: Juniper Pharmaceuticals to Explore Strategic Alternatives

Jan 02,2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Juniper Pharmaceuticals Inc-Key Facts 6

Juniper Pharmaceuticals Inc-Key Employees 7

Juniper Pharmaceuticals Inc-Key Employee Biographies 8

Juniper Pharmaceuticals Inc-Major Products and Services 9

Juniper Pharmaceuticals Inc-History 10

Juniper Pharmaceuticals Inc-Company Statement 13

Juniper Pharmaceuticals Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Company Overview 16

Juniper Pharmaceuticals Inc-Business Description 17

Business Segment: Product 17

Overview 17

Performance 17

Business Segment: Service 17

Overview 17

Performance 17

Geographical Segment: Other countries 18

Performance 18

Geographical Segment: Switzerland 18

Performance 18

Geographical Segment: The UK 18

Performance 18

Geographical Segment: The US 18

Performance 18

R&D Overview 18

Juniper Pharmaceuticals Inc-Corporate Strategy 19

Juniper Pharmaceuticals Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Juniper Pharmaceuticals Inc-Strengths 20

Juniper Pharmaceuticals Inc-Weaknesses 21

Juniper Pharmaceuticals Inc-Opportunities 22

Juniper Pharmaceuticals Inc-Threats 23

Juniper Pharmaceuticals Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Juniper Pharmaceuticals Inc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

May 10, 2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results 35

Mar 21, 2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors 36

Mar 08, 2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results 37

Jan 31, 2018: Juniper Pharmaceuticals to Explore Strategic Alternatives 39

Jan 02, 2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress 40

Nov 02, 2017: Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results 41

Sep 18, 2017: Juniper Pharmaceuticals Announces Strategic Reprioritization 42

Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors 44

Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors 45

Aug 08, 2017: Major Progress in Next Generation Medicines Initiative 46

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51

List of Figures

Juniper Pharmaceuticals Inc, Performance Chart (2013-2017) 29

Juniper Pharmaceuticals Inc, Ratio Charts 31

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

List of Tables

Juniper Pharmaceuticals Inc, Key Facts 6

Juniper Pharmaceuticals Inc, Key Employees 7

Juniper Pharmaceuticals Inc, Key Employee Biographies 8

Juniper Pharmaceuticals Inc, Major Products and Services 9

Juniper Pharmaceuticals Inc, History 10

Juniper Pharmaceuticals Inc, Subsidiaries 15

Juniper Pharmaceuticals Inc, Key Competitors 24

Juniper Pharmaceuticals Inc, Ratios based on current share price 25

Juniper Pharmaceuticals Inc, Annual Ratios 26

Juniper Pharmaceuticals Inc, Annual Ratios (Cont...1) 27

Juniper Pharmaceuticals Inc, Annual Ratios (Cont...2) 28

Juniper Pharmaceuticals Inc, Interim Ratios 30

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Juniper Pharmaceuticals Inc, Recent Deals Summary 34

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Unimed Pharmaceuticals LLC

Ferring Pharmaceuticals Inc

Auxilium Pharmaceuticals LLC

Astellas Pharma Inc

AbbVie Products LLC

Juniper Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8920
Site License
USD 250 INR 17840
Corporate User License
USD 375 INR 26760

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com